Maen Hussein, MDFinance Committee
Dr. Maen Hussein chose to become an oncologist to be part of the “amazing new discoveries” that are contributing to advancements in cancer treatment and bringing new hope to patients. He enjoys working with his patients and strives to always do more to help them feel better. Through his work with support groups, he helps educate patients and their families so that they are better equipped for their cancer journey.
Dr. Hussein has been providing oncology care to patients in community settings for nearly 20 years. He joined Florida Cancer Specialists in 2011.
An active cancer researcher and advocate for the vital importance of clinical trials, Dr. Hussein has served as Principal Investigator on numerous clinical trials with a focus on lung cancer. His work has been published and presented in prestigious industry publications and symposiums. Most recently, Dr. Hussein served as Principal Investigator and co-author of a clinical study that led to FDA approval of a new immunotherapy that improves chemotherapy treatment outcomes for patients with metastatic non small-cell lung cancer (mNSCLC).
After completing his residency at Brown University’s Memorial Hospital in Pawtucket, Rhode Island, Dr. Hussein was awarded a fellowship in Medical Oncology at St. Louis University in St. Louise, Missouri. He is Board-certified in Medical Oncology, Hematology and Internal Medicine.
Dr. Hussein currently serves on the Finance Committee of the FCS Executive Board and on the FCS Foundation Board of Directors, of which he is the Immediate Past Chair. He is also Vice President of the Florida Society of Clinical Oncology (FLASCO) Board of Directors.
In 2010, he was the recipient of the Leesburg Regional Medical Center Outstanding Achievement Award, Leesburg Regional Medical Center Foundation Hope in Healing Humanitarian Award in 2014 and was named Physician of the Quarter Award at Florida Hospital Waterman.
In his free time, Dr. Hussein enjoys playing recreational soccer, traveling, and spending quality time with family and friends.
Q&A with Medical Oncologist Dr. Maen Hussein: Lung Cancer
Lung cancer isn’t only developed through smoking. How can non-smokers protect themselves from this cancer?
There is no specific practice to protect yourself specifically from non-smoker-related lung cancer. Protecting your health in general — with exercise, avoiding second-hand smoke and committing to healthy diets, as well as avoiding other toxins such as marijuana, can possibly reduce the risk.
What can people who smoke, or have smoked, do to monitor their lung health?
Lung cancer screening is recommended for active smokers or people who quit within 15 years of reaching the age of 55 (and until the age of 79). Patients who meet this criterion should ask their primary care physicians about this low-dose CT chest scan.
What is the difference between lung cancers in smokers vs. non-smokers?
In general, smokers do worse than non-smokers when diagnosed with lung cancer. It could be because smokers may have other illnesses such as heart or lung disease, which makes it harder to be treated. Smoking can also weaken the immune system. There is data that shows when a patient quits smoking after starting treatment for lung cancer, they do better than patients who continue to smoke.
- Medical Oncology
- University of Jordan – Amman, Jordan
- Islamic Hospital | Amman, Jordan
- Albasheer General Hospital | Amman, Jordan
- Security Forces Hospital | Riyadh-KSA
- Brown University at Memorial Hospital of Rhode Island | Pawtucket, RI
- Saint Louis University | St. Louis, MO
- Medical Oncology
- Internal Medicine
Honors & Achievements
- Outstanding Achievement Award, 2010, Leesburg Regional Medical Center
- Physician of the Quarter Award at Florida Hospital Waterman
- Hope in Healing Humanitarian Award, 2014, Leesburg Regional Medical Center Foundation
- American Cancer Society
- American College of Physicians
- American Society of Clinical Oncology (ASCO)
- Community Oncology Alliance (COA)
- Florida Society of Clinical Oncology (FLASCO)